2026 Lisa A. Beck: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	80	1599	1457	798	714	348	32231
Medicine	81	16429	15451	8262	7644	374	32874

Overview

Lisa A. Beck is affiliated with the University of Rochester Medical Center in the United States. Their research primarily focuses on the field of Medicine with particular emphasis on Dermatology, Immunology and Allergy, Rheumatology, Physiology, and Immunology. The main topics addressed in their work include Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Urticaria and Related Conditions, Food Allergy and Anaphylaxis Research, Adrenal Hormones and Disorders, and IL-33, ST2, and ILC Pathways.

The scientist has published extensively, with significant contributions in several frequent publication venues. These include the Journal of the American Academy of Dermatology, Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology, British Journal of Dermatology, and Annals of Allergy Asthma & Immunology.

They have worked with multiple co-authors, some of the most frequent being Amy S. Paller, Eric L. Simpson, Mette Deleuran, Mark Boguniewicz, and Marjolein de Bruin-Weller.

Notable recent papers authored or co-authored by Lisa A. Beck include:

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIII trials, 2020, British Journal of Dermatology
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial, 2020, Journal of the American Academy of Dermatology
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis, 2022, JID Innovations
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis, 2020, Journal of the American Academy of Dermatology
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis, 2020, American Journal of Clinical Dermatology

Best Publications

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

2514
Citations
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

2113
Citations
Atopic dermatitis

Unknown

1643
Citations
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham

1539
Citations
Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel

Alkis Togias;Susan F. Cooper;Maria L. Acebal;Amal Assa'ad

1440
Citations
Cytokine modulation of atopic dermatitis filaggrin skin expression

Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant

1372
Citations
Tight junction defects in patients with atopic dermatitis.

Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov

844
Citations
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber

719
Citations
Activation of Airway Epithelial Cells by Toll-Like Receptor Agonists

Quan Sha;Ai Q. Truong-Tran;James R. Plitt;Lisa A. Beck

629
Citations
Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia

Megan L. Gill;Peter J. Grahn;Jonathan S. Calvert;Margaux B. Linde

572
Citations
Atopic dermatitis: A practice parameter update 2012

Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz

543
Citations
Omalizumab-induced reductions in mast cell FcεRI expression and function

Lisa A. Beck;Gregory V. Marcotte;Donald MacGlashan;Alkis Togias

537
Citations
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

528
Citations
Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

J.W. Simons;E.M. Jaffee;C.E. Weber;H.J. Levitsky

527
Citations
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Jennifer K Garrett;Sean C Jameson;Blythe Thomson;Margaret H Collins

493
Citations
Chemokines: Key Players in Innate and Adaptive Immunity

Clemens Esche;Cristiana Stellato;Lisa A. Beck

476
Citations
Atopic dermatitis: a disease caused by innate immune defects?

Anna De Benedetto;Ritesh Agnihothri;Laura Y. McGirt;Lora G. Bankova

457
Citations
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

398
Citations
Skin Barrier Disruption - A Requirement for Allergen Sensitization?

Anna De Benedetto;Akiharu Kubo;Lisa A. Beck

395
Citations
Cytokine modulation of atopic dermatitis filaggrin skin expression.

Unknown

368
Citations
Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions

Lisa A. Schwiebert;Lisa A. Beck;Cristiana Stellato;Carol A. Bickel

365
Citations
Atopic dermatitis and asthma: Parallels in the evolution of treatment

Lawrence F. Eichenfield;Jon M. Hanifin;Lisa A. Beck;Robert F. Lemanske

315
Citations

Frequent Co-Authors

Lynda C. Schneider Boston Children's Hospital

Jon M. Hanifin Oregon Health & Science University

Kathleen C. Barnes University of Colorado Denver

Donald Y.M. Leung National Jewish Health

Eric L. Simpson Oregon Health & Science University

Mark Boguniewicz National Jewish Health

Nicholas Rafaels University of Colorado Denver

Lawrence F. Eichenfield University of California, San Diego

Robert P. Schleimer Northwestern University

Rasika A. Mathias Johns Hopkins University

External Links

Personal website of Lisa A. Beck

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related online degrees such as psychiatric nurse practitioner programs can be a strategic choice. Many students seek online pmhnp programs with clinical placement, ensuring hands-on experience alongside theoretical learning. Clinical placements are crucial for building practical skills and easing the transition into healthcare roles.

Cost is another significant consideration. Prospective students often look for the cheapest pmhnp programs online to balance quality education with affordability. Financial accessibility can broaden opportunities for diverse candidates to advance their careers in immunology-related fields.

Career advancement within nursing can include paths like the Doctor of Nursing Practice (DNP). Understanding the doctor of nursing practice salary by state helps professionals make informed decisions about where to study or work, maximizing their earning potential in this specialized field.

Additionally, certification pathways such as the acute care nurse practitioner certification allow nurses to refine their expertise, especially when managing complex immunological cases. Transitioning between roles can expand career options and improve patient outcomes in immunology-related healthcare settings.